Vernalis plc

Company Information

Address:

Oakdene Court 613 Reading Road
Winnersh
Wokingham
Berkshire
RG41 5UA

Tel:

0118 977 3133

Fax:

0118 989 9300

E-Mail:

Secretary:

Alison Hood

Registrar:

Company Overview

Vernalis is a UK-based biotechnology company with a marketed product, Frovatriptan, to treat migraine and a development pipeline focused on CNS disease and oncology. The company has five products in clinical development and collaborations with leading, global pharmaceutical companies including Novartis, Biogen Idec and Serono. Vernalis is establishing a US commercial operation to co-promote frovatriptan alongside its North American licensing partner, Endo Pharmaceuticals, propelling the company towards its goal of becoming a sustainable, self-funding, R&D-driven biotechnology company.

Annual Reports

Description Report Date Published
Annual Report 200931-12-200909-04-2010
Annual Report 200831-12-200829-04-2009
Annual Report 200731-12-200712-05-2008

Interim Reports

Description Report Date Published
Interim Report 201030-06-201029-07-2010
Interim Report 200930-06-200906-08-2009
Interim Report 200830-06-200828-08-2008
Interim Report 200730-06-200713-09-2007

Dividend Histroy

Type Dividend Payment Date
A B C D E F G
H I J K L M
N O P Q R S T
U V W X Y Z #